Annual EBITDA
-$30.52 M
+$10.68 M+25.92%
December 31, 2021
Summary
- As of February 10, 2025, GNCA annual EBITDA is -$30.52 million, with the most recent change of +$10.68 million (+25.92%) on December 31, 2021.
- During the last 3 years, GNCA annual EBITDA has fallen by -$4.82 million (-18.74%).
Performance
GNCA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$15.35 M
-$2.75 M-21.78%
March 31, 2022
Summary
- As of February 10, 2025, GNCA quarterly EBITDA is -$15.35 million, with the most recent change of -$2.75 million (-21.78%) on March 31, 2022.
- Over the past year, GNCA quarterly EBITDA has dropped by -$4.02 million (-35.54%).
Performance
GNCA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$34.54 M
-$4.02 M-13.19%
March 31, 2022
Summary
- As of February 10, 2025, GNCA TTM EBITDA is -$34.54 million, with the most recent change of -$4.02 million (-13.19%) on March 31, 2022.
- Over the past year, GNCA TTM EBITDA has increased by +$5.66 million (+14.08%).
Performance
GNCA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GNCA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.9% | -35.5% | +14.1% |
| 3 y3 years | -18.7% | -2.4% | +6.4% |
| 5 y5 years | +43.2% | -18.7% | +6.4% |
GNCA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | +21.8% | at low | +13.2% | at low |
| 5 y | 5-year | at high | +35.0% | +422.9% | at low | +13.2% | +19.3% |
| alltime | all time | +143.0% | +76.1% | -1739.6% | +5.2% | +676.7% | +70.1% |
Genocea Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$15.35 M(+21.8%) | -$34.54 M(+13.2%) |
| Dec 2021 | -$30.52 M(-25.9%) | -$12.60 M(+329.4%) | -$30.52 M(-5.4%) |
| Sep 2021 | - | -$2.94 M(-19.8%) | -$32.25 M(-2.8%) |
| Jun 2021 | - | -$3.66 M(-67.7%) | -$33.18 M(-17.5%) |
| Mar 2021 | - | -$11.32 M(-21.0%) | -$40.20 M(-2.4%) |
| Dec 2020 | -$41.20 M(+11.6%) | -$14.34 M(+270.7%) | -$41.20 M(+15.2%) |
| Sep 2020 | - | -$3.87 M(-63.8%) | -$35.75 M(-8.3%) |
| Jun 2020 | - | -$10.68 M(-13.3%) | -$38.99 M(+13.9%) |
| Mar 2020 | - | -$12.32 M(+38.5%) | -$34.23 M(-7.2%) |
| Dec 2019 | -$36.91 M(+43.6%) | -$8.89 M(+25.2%) | -$36.91 M(+36.3%) |
| Sep 2019 | - | -$7.10 M(+20.0%) | -$27.08 M(-0.7%) |
| Jun 2019 | - | -$5.92 M(-60.5%) | -$27.27 M(+7.9%) |
| Mar 2019 | - | -$14.99 M(-1701.8%) | -$25.28 M(-1.7%) |
| Dec 2018 | -$25.70 M(-52.2%) | $936.00 K(-112.8%) | -$25.70 M(-30.0%) |
| Sep 2018 | - | -$7.29 M(+85.9%) | -$36.74 M(-19.4%) |
| Jun 2018 | - | -$3.92 M(-74.6%) | -$45.59 M(-18.9%) |
| Mar 2018 | - | -$15.42 M(+52.6%) | -$56.24 M(+4.6%) |
| Dec 2017 | -$53.75 M | -$10.10 M(-37.4%) | -$53.75 M(-8.5%) |
| Sep 2017 | - | -$16.15 M(+10.8%) | -$58.74 M(+7.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | -$14.58 M(+12.8%) | -$54.44 M(+8.9%) |
| Mar 2017 | - | -$12.93 M(-14.3%) | -$49.99 M(+8.6%) |
| Dec 2016 | -$46.02 M(+14.6%) | -$15.09 M(+27.4%) | -$46.02 M(+13.6%) |
| Sep 2016 | - | -$11.85 M(+17.0%) | -$40.52 M(+7.0%) |
| Jun 2016 | - | -$10.13 M(+13.0%) | -$37.86 M(+0.9%) |
| Mar 2016 | - | -$8.96 M(-6.6%) | -$37.53 M(-6.5%) |
| Dec 2015 | -$40.15 M(+18.8%) | -$9.59 M(+4.5%) | -$40.15 M(-3.7%) |
| Sep 2015 | - | -$9.18 M(-6.3%) | -$41.70 M(+0.9%) |
| Jun 2015 | - | -$9.80 M(-15.4%) | -$41.34 M(+7.7%) |
| Mar 2015 | - | -$11.59 M(+4.0%) | -$38.37 M(+13.5%) |
| Dec 2014 | -$33.80 M(+68.8%) | -$11.13 M(+26.2%) | -$33.80 M(+17.3%) |
| Sep 2014 | - | -$8.82 M(+29.2%) | -$28.80 M(+16.8%) |
| Jun 2014 | - | -$6.83 M(-2.7%) | -$24.66 M(+9.1%) |
| Mar 2014 | - | -$7.02 M(+14.4%) | -$22.60 M(+12.8%) |
| Dec 2013 | -$20.03 M(+59.5%) | -$6.14 M(+31.3%) | -$20.03 M(+9.2%) |
| Sep 2013 | - | -$4.68 M(-1.8%) | -$18.34 M(+34.2%) |
| Jun 2013 | - | -$4.76 M(+7.0%) | -$13.66 M(+53.5%) |
| Mar 2013 | - | -$4.45 M(+0.1%) | -$8.90 M(+100.1%) |
| Dec 2012 | -$12.56 M(-12.4%) | -$4.45 M | -$4.45 M |
| Dec 2011 | -$14.33 M | - | - |
FAQ
- What is Genocea Biosciences annual EBITDA?
- What is the all time high annual EBITDA for Genocea Biosciences?
- What is Genocea Biosciences annual EBITDA year-on-year change?
- What is Genocea Biosciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Genocea Biosciences?
- What is Genocea Biosciences quarterly EBITDA year-on-year change?
- What is Genocea Biosciences TTM EBITDA?
- What is the all time high TTM EBITDA for Genocea Biosciences?
- What is Genocea Biosciences TTM EBITDA year-on-year change?
What is Genocea Biosciences annual EBITDA?
The current annual EBITDA of GNCA is -$30.52 M
What is the all time high annual EBITDA for Genocea Biosciences?
Genocea Biosciences all-time high annual EBITDA is -$12.56 M
What is Genocea Biosciences annual EBITDA year-on-year change?
Over the past year, GNCA annual EBITDA has changed by +$10.68 M (+25.92%)
What is Genocea Biosciences quarterly EBITDA?
The current quarterly EBITDA of GNCA is -$15.35 M
What is the all time high quarterly EBITDA for Genocea Biosciences?
Genocea Biosciences all-time high quarterly EBITDA is $936.00 K
What is Genocea Biosciences quarterly EBITDA year-on-year change?
Over the past year, GNCA quarterly EBITDA has changed by -$4.02 M (-35.54%)
What is Genocea Biosciences TTM EBITDA?
The current TTM EBITDA of GNCA is -$34.54 M
What is the all time high TTM EBITDA for Genocea Biosciences?
Genocea Biosciences all-time high TTM EBITDA is -$4.45 M
What is Genocea Biosciences TTM EBITDA year-on-year change?
Over the past year, GNCA TTM EBITDA has changed by +$5.66 M (+14.08%)